Sooo, the relapse kinetics of ifn monotherapy and ifn+rib may not be that different. But/thus SVR12 might actually be a very good proxy for SVR24.
So, should I infer that you believe that SVR12 may be a good proxy for SVR24 as well where a combo of HCV DAAs are involved (with or without ifn or ifn+rib)?
Has VRTX itself posted SVR12 data from any of its telaprevir trials where we can compare the SVR12 numbers to the SVR24 numbers?